COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
May 2014

20

May
2014

category:

503b Compounding

Synergistic Approach to Serialization And The Drug Quality & Security Act

Hang around pharmaceutical drug manufacturers long enough and the conversation will undoubtedly turn to the global dilemma of safeguarding the public from the proliferation of counterfeit drugs, and the Drug Quality and Security Act (DQSA). Now a law, the DQSA includes a phased timeline, extending to 2023, that requires U.S. prescription drug manufacturers to comply […]

read more

20

May
2014

category:

503b Compounding

Three Questions To Consider For DQSA Readiness

Last November, after much anticipation, the U.S. pharmaceutical industry saw the enactment of the Drug Quality and Security Act (DQSA), which includes in Title II theDrug Supply Chain Security Act (DSCSA). The DSCSA addresses national pharmaceutical track and trace requirements, and industry stakeholders must now prepare themselves for the first round of deadlines for lot-level […]

read more

20

May
2014

category:

503b Compounding

Settlement Seeks $100M Fund for Meningitis Victims

A settlement filed with a federal bankruptcy judge would create a fund of more than $100 million to compensate victims of a nationwide meningitis outbreak linked to a Massachusetts pharmacy, lawyers said on May 6. The outbreak, blamed on a tainted steroid produced by the New England Compounding Center, sickened more than 750 people in […]

read more